Brian's breakthrough in cancer diagnosis.

L. Pearce

DOI: https://doi.org/10.7748/ns2014.04.28.35.20.s25

2014-05-06

Nursing Standard

Abstract:

What problem does this paper attempt to address?

Using sensor-fusion and machine-learning algorithms to assess acute pain in non-verbal infants: a study protocol

Jean-Michel Roué,Iris Morag,Wassim M Haddad,Behnood Gholami,Kanwaljeet J S Anand

DOI: https://doi.org/10.1136/bmjopen-2020-039292

IF: 3.006

2021-01-01

BMJ Open

Abstract:Introduction Objective pain assessment in non-verbal populations is clinically challenging due to their inability to express their pain via self-report. Repetitive exposures to acute or prolonged pain lead to clinical instability, with long-term behavioural and cognitive sequelae in newborn infants. Strong analgesics are also associated with medical complications, potential neurotoxicity and altered brain development. Pain scores performed by bedside nurses provide subjective, observer-dependent assessments rather than objective data for infant pain management; the required observations are labour intensive, difficult to perform by a nurse who is concurrently performing the procedure and increase the nursing workload. Multimodal pain assessment, using sensor-fusion and machine-learning algorithms, can provide a patient-centred, context-dependent, observer-independent and objective pain measure. Methods and analysis In newborns undergoing painful procedures, we use facial electromyography to record facial muscle activity-related infant pain, ECG to examine heart rate (HR) changes and HR variability, electrodermal activity (skin conductance) to measure catecholamine-induced palmar sweating, changes in oxygen saturations and skin perfusion, and electroencephalography using active electrodes to assess brain activity in real time. This multimodal approach has the potential to improve the accuracy of pain assessment in non-verbal infants and may even allow continuous pain monitoring at the bedside. The feasibility of this approach will be evaluated in an observational prospective study of clinically required painful procedures in 60 preterm and term newborns, and infants aged 6 months or less. Ethics and dissemination The Institutional Review Board of the Stanford University approved the protocol. Study findings will be published in peer-reviewed journals, presented at scientific meetings, taught via webinars, podcasts and video tutorials, and listed on academic/scientific websites. Future studies will validate and refine this approach using the minimum number of sensors required to assess neonatal/infant pain. Trial registration number ClinicalTrials.gov Registry ( NCT03330496 ).

medicine, general & internal
Multimodal physiological sensing for the assessment of acute pain

Raul Fernandez Rojas,Niraj Hirachan,Nicholas Brown,Gordon Waddington,Luke Murtagh,Ben Seymour,Roland Goecke

DOI: https://doi.org/10.3389/fpain.2023.1150264

2023-06-19

Frontiers in Pain Research

Abstract:Pain assessment is a challenging task encountered by clinicians. In clinical settings, patients’ self-report is considered the gold standard in pain assessment. However, patients who are unable to self-report pain are at a higher risk of undiagnosed pain. In the present study, we explore the use of multiple sensing technologies to monitor physiological changes that can be used as a proxy for objective measurement of acute pain. Electrodermal activity (EDA), photoplethysmography (PPG), and respiration (RESP) signals were collected from 22 participants under two pain intensities (low and high) and on two different anatomical locations (forearm and hand). Three machine learning models were implemented, including support vector machines (SVM), decision trees (DT), and linear discriminant analysis (LDA) for the identification of pain. Various pain scenarios were investigated, identification of pain (no pain, pain), multiclass (no pain, low pain, high pain), and identification of pain location (forearm, hand). Reference classification results from individual sensors and from all sensors together were obtained. After feature selection, results showed that EDA was the most informative sensor in the three pain conditions, 93.2 ± 8 % in identification of pain, 68.9 ± 10 % in the multiclass problem, and 56.0 ± 8 % for the identification of pain location. These results identify EDA as the superior sensor in our experimental conditions. Future work is required to validate the obtained features to improve its feasibility in more realistic scenarios. Finally, this study proposes EDA as a candidate to design a tool that can assist clinicians in the assessment of acute pain of nonverbal patients.
Brain-Computer Interface to Deliver Individualized Multisensory Intervention for Neuropathic Pain

Giuseppe Valerio Aurucci,Greta Preatoni,Arianna Damiani,Stanisa Raspopovic

DOI: https://doi.org/10.1007/s13311-023-01396-y

IF: 6.088

Neurotherapeutics

Abstract:To unravel the complexity of the neuropathic pain experience, researchers have tried to identify reliable pain signatures (biomarkers) using electroencephalography (EEG) and skin conductance (SC). Nevertheless, their use as a clinical aid to design personalized therapies remains scarce and patients are prescribed with common and inefficient painkillers. To address this need, novel non-pharmacological interventions, such as transcutaneous electrical nerve stimulation (TENS) to activate peripheral pain relief via neuromodulation and virtual reality (VR) to modulate patients' attention, have emerged. However, all present treatments suffer from the inherent bias of the patient's self-reported pain intensity, depending on their predisposition and tolerance, together with unspecific, pre-defined scheduling of sessions which does not consider the timing of pain episodes onset. Here, we show a Brain-Computer Interface (BCI) detecting in real-time neurophysiological signatures of neuropathic pain from EEG combined with SC and accordingly triggering a multisensory intervention combining TENS and VR. After validating that the multisensory intervention effectively decreased experimentally induced pain, the BCI was tested with thirteen healthy subjects by electrically inducing pain and showed 82% recall in decoding pain in real time. Such constructed BCI was then validated with eight neuropathic patients reaching 75% online pain precision, and consequently releasing the intervention inducing a significant decrease (50% NPSI score) in neuropathic patients' pain perception. Our results demonstrate the feasibility of real-time pain detection from objective neurophysiological signals, and the effectiveness of a triggered combination of VR and TENS to decrease neuropathic pain. This paves the way towards personalized, data-driven pain therapies using fully portable technologies.
Advancing the integration of biosignal-based automated pain assessment methods into a comprehensive model for addressing cancer pain

Marco Cascella,Piergiacomo Di Gennaro,Anna Crispo,Alessandro Vittori,Emiliano Petrucci,Francesco Sciorio,Franco Marinangeli,Alfonso Maria Ponsiglione,Maria Romano,Concetta Ovetta,Alessandro Ottaiano,Francesco Sabbatino,Francesco Perri,Ornella Piazza,Sergio Coluccia

DOI: https://doi.org/10.1186/s12904-024-01526-z

2024-08-03

Abstract:Background: Tailoring effective strategies for cancer pain management requires a careful analysis of multiple factors that influence pain phenomena and, ultimately, guide the therapy. While there is a wealth of research on automatic pain assessment (APA), its integration with clinical data remains inadequately explored. This study aimed to address the potential correlations between subjective and APA-derived objectives variables in a cohort of cancer patients. Methods: A multidimensional statistical approach was employed. Demographic, clinical, and pain-related variables were examined. Objective measures included electrodermal activity (EDA) and electrocardiogram (ECG) signals. Sensitivity analysis, multiple factorial analysis (MFA), hierarchical clustering on principal components (HCPC), and multivariable regression were used for data analysis. Results: The study analyzed data from 64 cancer patients. MFA revealed correlations between pain intensity, type, Eastern Cooperative Oncology Group Performance status (ECOG), opioids, and metastases. Clustering identified three distinct patient groups based on pain characteristics, treatments, and ECOG. Multivariable regression analysis showed associations between pain intensity, ECOG, type of breakthrough cancer pain, and opioid dosages. The analyses failed to find a correlation between subjective and objective pain variables. Conclusions: The reported pain perception is unrelated to the objective variables of APA. An in-depth investigation of APA is required to understand the variables to be studied, the operational modalities, and above all, strategies for appropriate integration with data obtained from self-reporting. Trial registration: This study is registered with ClinicalTrials.gov, number (NCT04726228), registered 27 January 2021, https://classic. Clinicaltrials: gov/ct2/show/NCT04726228?term=nct04726228&draw=2&rank=1.
Pain chronification risk assessment: advanced phenotyping and scoring for prediction and treatments tailored to individualized patient profile

Igor Martuliak,Olga Golubnitschaja,Lubos Chvala,Marko Kapalla,Miroslav Ferencik,Michala Bubeliny,Michal Venglarcik,Ladislav Kocan

DOI: https://doi.org/10.1007/s13167-024-00383-3

IF: 6.5

2024-11-20

The EPMA Journal

Abstract:Acute pain is a physiologic, protective life-important warning neurological signal indicating multi-level tissue modulations caused by a broad spectrum of health adverse events such as stress overload, mechanical trauma, ischemia–reperfusion, sterile and infection-triggered inflammation, single- and multi-organ damage, acute and chronic wounds, tissue remodeling and degeneration, amongst others. On the other hand, pain chronification results in a pathologic transformation from the protective pain signaling into persistent debilitative medical condition with severe consequences including but not restricted to phenotype-specific behavioral patterns, reduced quality of life, and cognitive and mood disorders. Who is predisposed to an increased vs. decreased pain sensitivity and to the pain chronification? The motivation of personalized medicine that "same size does not fit all" is getting obvious also for an advanced approach in algesiology. Consequently, an in-depth patient stratification is essential for the paradigm change in overall pain management from currently applied reactive medical services to the cost-effective predictive, preventive, and personalized medicine (PPPM/3PM) in primary (reversible damage to health and targeted protection against health-to-disease transition) and secondary (personalized protection against disease progression) care. To this end, specifically innovative concepts of phenotyping elaborated in this study play a crucial role in patient stratification for predicting pain-associated outcomes, evidence-based targeted prevention of the pain chronification, and creation of treatment algorithms tailored to individualized patient profiles.

medicine, research & experimental
Emotion Processing in Peripheral Neuropathic Pain: An Observational Study

Gianluca Isoardo,Mauro Adenzato,Stefano Ciullo,Elena Fontana,Ilaria Stura,Giuseppe Migliaretti,Paolo Titolo,Enrico Matteoni,Andrea Calvo,Federica Laino,Francesca Palumbo,Rita B Ardito

DOI: https://doi.org/10.3390/medsci12020027

2024-05-17

Abstract:Background: In clinical practice, the implementation of tailored treatment is crucial for assessing the patient's emotional processing profile. Here, we investigate all three levels of analysis characterizing emotion processing, i.e., recognition, representation, and regulation, in patients with peripheral neuropathic pain (PNP). Methods: Sixty-two patients and forty-eight healthy controls underwent quantitative sensory testing, i.e., psychophysical tests to assess somatosensory functions such as perception of cold (CDT), heat-induced pain (HPT), and vibration (VDT), as well as three standardized tasks to assess emotional processing: (1) the Ekman 60-Faces Test (EK-60F) to assess recognition of basic facial emotions, (2) the Reading the Mind in the Eyes Test (RME) to assess the ability to represent the feelings of another person by observing their eyes, and (3) the 20-item Toronto Alexithymia Scale (TAS-20) to assess emotional dysregulation, i.e., alexithymia. Results: General Linear Model analysis revealed a significant relationship between left index finger VDT z-scores in PNP patients with alexithymia. The RME correlated with VDT z-scores of the left little finger and overall score for the EK-60F. Conclusions: In patients with PNP, emotion processing is impaired, which emphasizes the importance of assessing these abilities appropriately in these patients. In this way, clinicians can tailor treatment to the needs of individual patients.
Disease Phenotypes in Refractory Musculoskeletal Pain Syndromes Identified by Unsupervised Machine Learning

Thomas Hügle,Tiffany Prétat,Marc Suter,Chris Lovejoy,Pedro Ming Azevedo

DOI: https://doi.org/10.1002/acr2.11699

Abstract:Objective: Overlapping chronic pain syndromes, including fibromyalgia, are heterogeneous and often treatment-resistant entities carrying significant socioeconomic burdens. Individualized treatment approaches from both a somatic and psychological side are necessary to improve patient care. The objective of this study was to identify and visualize patient clusters in refractory musculoskeletal pain syndromes through an extensive set of clinical variables, including immunologic, psychosomatic, wearable, and sleep biomarkers. Methods: Data were collected during a multimodal pain program involving 202 patients. Seventy-eight percent of the patients fulfilled the criteria for fibromyalgia, 77% had a concomitant psychiatric-mediated disorder, and 22% a concomitant rheumatic immune-mediated disorder. Five patient phenotypes were identified by hierarchical agglomerative clustering as a form of unsupervised learning, and a predictive model for the Brief Pain Inventory (BPI) response was generated. Based on the clustering data, digital personas were created with DALL-E (OpenAI). Results: The most relevant distinguishing factors among clusters were living alone, body mass index, peripheral joint pain, alexithymia, psychiatric comorbidity, childhood pain, neuroleptic or benzodiazepine medication, and response to virtual reality. Having an immune-mediated disorder was not discriminatory. Three of five clusters responded to the multimodal treatment in terms of pain (BPI intensity), one cluster responded in terms of functional improvement (BPI interference), and one cluster notably responded to the virtual reality intervention. The independent predictive model confirmed strong opioids, trazodone, neuroleptic treatment, and living alone as the most important negative predictive factors for reduced pain after the program. Conclusion: Our model identified and visualized clinically relevant chronic musculoskeletal pain subtypes and predicted their response to multimodal treatment. Such digital personas and avatars may play a future role in the design of personalized therapeutic modalities and clinical trials.
Naturalistic acute pain states decoded from neural and facial dynamics

Yuhao Huang,Jay Gopal,Bina Kakusa,Alice Li,Weichen Huang,Jeffrey B Wang,Amit Persad,Ashwin Ramayya,Josef Parvizi,Vivek P Buch,Corey Keller

DOI: https://doi.org/10.1101/2024.05.10.593652

2024-05-12

Abstract:Pain is a complex experience that remains largely unexplored in naturalistic contexts, hindering our understanding of its neurobehavioral representation in ecologically valid settings. To address this, we employed a multimodal, data-driven approach integrating intracranial electroencephalography, pain self-reports, and facial expression quantification to characterize the neural and behavioral correlates of naturalistic acute pain in twelve epilepsy patients undergoing continuous monitoring with neural and audiovisual recordings. High self-reported pain states were associated with elevated blood pressure, increased pain medication use, and distinct facial muscle activations. Using machine learning, we successfully decoded individual participants' high versus low self-reported pain states from distributed neural activity patterns (mean AUC = 0.70), involving mesolimbic regions, striatum, and temporoparietal cortex. High self-reported pain states exhibited increased low-frequency activity in temporoparietal areas and decreased high-frequency activity in mesolimbic regions (hippocampus, cingulate, and orbitofrontal cortex) compared to low pain states. This neural pain representation remained stable for hours and was modulated by pain onset and relief. Objective facial expression changes also classified self-reported pain states, with results concordant with electrophysiological predictions. Importantly, we identified transient periods of momentary pain as a distinct naturalistic acute pain measure, which could be reliably differentiated from affect-neutral periods using intracranial and facial features, albeit with neural and facial patterns distinct from self-reported pain. These findings reveal reliable neurobehavioral markers of naturalistic acute pain across contexts and timescales, underscoring the potential for developing personalized pain interventions in real-world settings.

Neuroscience
Targeted neural stimulation congruent with immersive reality decreases neuropathic pain

Giuseppe Valerio Aurucci,Noemi Gozzi,Markus Wagner,Greta Preatoni,Nicola Brunello,Natalija Katic Secerovic,Carl Zipser,Stanisa Raspopovic

DOI: https://doi.org/10.1101/2024.12.10.24318374

2024-12-11

Abstract:Chronic neuropathic pain is a complex experience, posing a major challenge in personalizing its treatment. Present treatments consist of non-specific, standardized drugs that are often addictive, leaving many patients non-respondent and with significant side effects. Designing individualized therapies requires targeting the multidimensionality of pain and developing objective endpoints to demonstrate their effectiveness. Currently, non-pharmacological alternatives are emerging, such as neurostimulation and Virtual Reality (VR), activating pain relief via peripheral neuromodulation and attention modulation. Similarly to drugs, many neurostimulation approaches are unspecific, targeting areas near the pain site and disregarding the neural pathway of pain. Above all, neurostimulation and VR are yet to be evaluated as a combined synergistic intervention, particularly in a randomized controlled trial (RCT). To this aim, we developed a targeted neurostimulation congruent with immersive VR platform providing a multisensory pain intervention through the synergistic application of somatotopic electro-tactile and visual stimuli. The endpoints included measuring sensory, neurophysiological (EEG), and self-reported indicators of pain. We tested the efficacy of the multisensory intervention against the control consisting of VR-only intervention on four consecutive intervention days in an RCT (N=18 neuropathic patients). The multisensory intervention resulted in a clinically significant reduction of pain (>50%), lasting up to one-week follow-up. The provided analgesic effect was statistically stronger compared to the VR-only control across treatment days and at follow-up. The clinically relevant pain decrease was accompanied with objective improvements in tactile acuity, proprioceptive measures, and changes in EEG pain biomarkers for the multisensory intervention group only. The proposed treatment paves the way toward multisensory, personalized, non-pharmacological, and effective solutions for chronic neuropathic pain.
Two new cyclophilins from Fusarium sambucinum and Aspergillus niger: resistance of cyclophilin/cyclosporin A complexes against proteolysis.

T. Hornbogen,R. Pieper,K. Hoffmann,H. Kleinkauf,R. Zocher

DOI: https://doi.org/10.1016/0006-291X(92)91265-R

1992-09-16

Abstract:
Predicting pain genes: multi-modal data integration using probabilistic classifiers and interaction networks

Na Zhao,David L Bennett,Georgios Baskozos,Allison M Barry

DOI: https://doi.org/10.1101/2024.05.15.594305

2024-09-17

Abstract:Accurate identification of pain-related genes remains challenging due to the complex nature of pain pathophysiology and the subjective nature of pain reporting in humans, or inferring pain states in animals on the basis of behaviour. Here, we use a machine learning approach to identify possible pain genes. Labelling was based on a gold-standard list of genes with validated involvement across pain conditions, and was trained on a selection of -omics (eg. transcriptomics, proteomics, etc.), protein-protein interaction (PPI) network features, and biological function readouts for each gene. Multiple classifiers were trained, and the top-performing model was selected to predict a pain score per gene. The top ranked genes were then validated against pain-related human SNPs to validate against human genetics studies. Functional analysis revealed JAK2/STAT3 signal, ErbB, and Rap1 signalling pathways as promising targets for further exploration, while network topological features contribute significantly to the identification of pain genes. As such, a PPI network based on top-ranked genes was constructed to reveal previously uncharacterised pain-related genes including CHRFAM7A and UNC79. These analyses can be further explored using the linked open-source database at https://livedataoxford.shinyapps.io/drg-directory, which is accompanied by a freely accessible code template and user guide for wider adoption across disciplines. Together, the novel insights into pain pathogenesis can indicate promising directions for future experimental research.

Bioinformatics
BLOOD PROTEOMICS AND PAIN - A TRANSLATIONAL STUDY TO PROGNOSTICATE PAIN PHENOTYPES AND ASSESS NEW BIOMARKERS FOR PREVENTING PAIN IN HUMANS

Daniel Segelcke,Julia R Sondermann,Christin Kappert,Bruno Pradier,Dennis Goerlich,Manfred Fobker,Jan Vollert,Peter K. Zahn,Manuela Schmidt,Esther M. Pogatzki-Zahn

DOI: https://doi.org/10.1101/2024.07.04.24309933

2024-07-05

Abstract:Personalized strategies in pain management and prevention should be based on individual risk factors as early as possible, but the factors most relevant are not yet known. An innovative approach would be to integrate multi-modal risk factors, including blood proteomics, in predicting high pain responders and using them as targets for personalized treatment options. Here, we determined and mapped multi-modal factors to prognosticate a phenotype with high risk of developing pain and hyperalgesia after an experimental incision in humans. We profiled unbiased blood plasma proteome signature of 26 male volunteers, assessed psychophysical and psychological aspects before incision injury. Outcome measures were pain intensity ratings and the extent of the area of hyperalgesia to mechanical stimuli surrounding the incision as a proxy for central sensitization. Phenotype-based stratification resulted in the identification of low- and high-responders for the two different outcome measures. Logistic regression analysis revealed prognostic potential for blood plasma proteins and for psychophysical and psychological parameters. The combination of certain parameters increased the prognostic accuracy for both outcome measures, exceeding 97%. In high-responders, term-term-interaction network analysis showed a proteome signature of a low-grade inflammation reaction. Intriguingly, in silico drug repurposing indicates a high potential for specific antidiabetic and anti-inflammatory drugs already available. In conclusion, we show an integrated pipeline that provides a valuable resource for patient stratification and the identification of (i) multi-feature prognostic models, (ii) treatment targets, and (iii) mechanistic correlates that may be relevant for individualized management of pain and its long-term consequences.
Physiological and behavioral profiling for nociceptive pain estimation using personalized multitask learning

Daniel Lopez-Martinez,Ognjen Rudovic,Rosalind Picard

DOI: https://doi.org/10.48550/arXiv.1711.04036

IF: 14.4

2017-11-10

Artificial Intelligence

Abstract:Pain is a subjective experience commonly measured through patient's self report. While there exist numerous situations in which automatic pain estimation methods may be preferred, inter-subject variability in physiological and behavioral pain responses has hindered the development of such methods. In this work, we address this problem by introducing a novel personalized multitask machine learning method for pain estimation based on individual physiological and behavioral pain response profiles, and show its advantages in a dataset containing multimodal responses to nociceptive heat pain.
Experimental Exploration of Objective Human Pain Assessment Using Multimodal Sensing Signals

Yingzi Lin,Yan Xiao,Li Wang,Yikang Guo,Wenchao Zhu,Biren Dalip,Sagar Kamarthi,Kristin L. Schreiber,Robert R. Edwards,Richard D. Urman

DOI: https://doi.org/10.3389/fnins.2022.831627

IF: 4.3

2022-02-11

Frontiers in Neuroscience

Abstract:Optimization of pain assessment and treatment is an active area of research in healthcare. The purpose of this research is to create an objective pain intensity estimation system based on multimodal sensing signals through experimental studies. Twenty eight healthy subjects were recruited at Northeastern University. Nine physiological modalities were utilized in this research, namely facial expressions (FE), electroencephalography (EEG), eye movement (EM), skin conductance (SC), and blood volume pulse (BVP), electromyography (EMG), respiration rate (RR), skin temperature (ST), blood pressure (BP). Statistical analysis and machine learning algorithms were deployed to analyze the physiological data. FE, EEG, SC, BVP, and BP proved to be able to detect different pain states from healthy subjects. Multi-modalities proved to be promising in detecting different levels of painful states. A decision-level multi-modal fusion also proved to be efficient and accurate in classifying painful states.

neurosciences
PainMeter: Automatic Assessment of Pain Intensity Levels From Multiple Physiological Signals Using Machine Learning

Da’ad Albahdal,Wijdan Aljebreen,Dina M. Ibrahim

DOI: https://doi.org/10.1109/access.2024.3384359

IF: 3.9

2024-04-09

IEEE Access

Abstract:Pain assessment traditionally relies on self-report, but it is subjective and influenced by various factors. To address this, there's a need for an affordable and scalable objective pain identification method. Current research suggests that pain has physiological markers beyond the brain, such as changes in cardiovascular activity and electrodermal responses. Utilizing these markers, real-time pain detection algorithms were developed using the BioVid Heat Pain dataset, consisting of 86 healthy individuals experiencing acute pain. Three physiological signals were collected (ECG, GSR, EMG). Various machine learning models were employed to lay the foundation for future advancements in creating sophisticated pain categorization algorithms. The goal is to develop a machine learning model capable of accurately classifying levels of pain experienced based solely on physiological signals. The proposed method produced an accuracy score of 87% for binary classification and 52% accuracy for multi-class classification, with the highest-performing machine learning model being Random Forests. These results suggest that the PainMeter can be deployed in field settings using wearable sensors, offering real-time, unbiased pain sensing and management capabilities.

computer science, information systems,telecommunications,engineering, electrical & electronic
Feasibility interventional study investigating PAIN in neurorehabilitation through wearabLE SensorS (PAINLESS): a study protocol

Serena Moscato,Silvia Orlandi,Francesco Di Gregorio,Giada Lullini,Stefania Pozzi,Loredana Sabattini,Lorenzo Chiari,Fabio La Porta

DOI: https://doi.org/10.1136/bmjopen-2023-073534

IF: 3.006

2023-11-22

BMJ Open

Abstract:Introduction: Millions of people survive injuries to the central or peripheral nervous system for which neurorehabilitation is required. In addition to the physical and cognitive impairments, many neurorehabilitation patients experience pain, often not widely recognised and inadequately treated. This is particularly true for multiple sclerosis (MS) patients, for whom pain is one of the most common symptoms. In clinical practice, pain assessment is usually conducted based on a subjective estimate. This approach can lead to inaccurate evaluations due to the influence of numerous factors, including emotional or cognitive aspects. To date, no objective and simple to use clinical methods allow objective quantification of pain and the diagnostic differentiation between the two main types of pain (nociceptive vs neuropathic). Wearable technologies and artificial intelligence (AI) have the potential to bridge this gap by continuously monitoring patients' health parameters and extracting meaningful information from them. Therefore, we propose to develop a new automatic AI-powered tool to assess pain and its characteristics during neurorehabilitation treatments using physiological signals collected by wearable sensors. Methods and analysis: We aim to recruit 15 participants suffering from MS undergoing physiotherapy treatment. During the study, participants will wear a wristband for three consecutive days and be monitored before and after their physiotherapy sessions. Measurement of traditionally used pain assessment questionnaires and scales (ie, painDETECT, Doleur Neuropathique 4 Questions, EuroQoL-5-dimension-3-level) and physiological signals (photoplethysmography, electrodermal activity, skin temperature, accelerometer data) will be collected. Relevant parameters from physiological signals will be identified, and AI algorithms will be used to develop automatic classification methods. Ethics and dissemination: The study has been approved by the local Ethical Committee (285-2022-SPER-AUSLBO). Participants are required to provide written informed consent. The results will be disseminated through contributions to international conferences and scientific journals, and they will also be included in a doctoral dissertation. Trial registration number: NCT05747040.
PainPoints: A Framework for Language-based Detection of Chronic Pain and Expert-Collaborative Text-Summarization

Shreyas Fadnavis,Amit Dhurandhar,Raquel Norel,Jenna M Reinen,Carla Agurto,Erica Secchettin,Vittorio Schweiger,Giovanni Perini,Guillermo Cecchi

DOI: https://doi.org/10.48550/arXiv.2209.09814

2022-09-14

Abstract:Chronic pain is a pervasive disorder which is often very disabling and is associated with comorbidities such as depression and anxiety. Neuropathic Pain (NP) is a common sub-type which is often caused due to nerve damage and has a known pathophysiology. Another common sub-type is Fibromyalgia (FM) which is described as musculoskeletal, diffuse pain that is widespread through the body. The pathophysiology of FM is poorly understood, making it very hard to diagnose. Standard medications and treatments for FM and NP differ from one another and if misdiagnosed it can cause an increase in symptom severity. To overcome this difficulty, we propose a novel framework, PainPoints, which accurately detects the sub-type of pain and generates clinical notes via summarizing the patient interviews. Specifically, PainPoints makes use of large language models to perform sentence-level classification of the text obtained from interviews of FM and NP patients with a reliable AUC of 0.83. Using a sufficiency-based interpretability approach, we explain how the fine-tuned model accurately picks up on the nuances that patients use to describe their pain. Finally, we generate summaries of these interviews via expert interventions by introducing a novel facet-based approach. PainPoints thus enables practitioners to add/drop facets and generate a custom summary based on the notion of "facet-coverage" which is also introduced in this work.

Computation and Language,Artificial Intelligence,Machine Learning
Objective Pain Assessment: a Key for the Management of Chronic Pain

Xiaohan Xu,Yuguang Huang

DOI: https://doi.org/10.12688/f1000research.20441.1

2020-01-23

F1000Research

Abstract:The individual and social burdens associated with chronic pain have been escalating globally. Accurate pain measurement facilitates early diagnosis, disease progression monitoring and therapeutic efficacy evaluation, thus is a key for the management of chronic pain. Although the “golden standards” of pain measurement are self-reported scales in clinical practice, the reliability of these subjective methods could be easily affected by patients’ physiological and psychological status, as well as the assessors’ predispositions. Therefore, objective pain assessment has attracted substantial attention recently. Previous studies of functional magnetic resonance imaging (fMRI) revealed that certain cortices and subcortical areas are commonly activated in subjects suffering from pain. Dynamic pain connectome analysis also found various alterations of neural network connectivity that are correlated with the severity of clinical pain symptoms. Electroencephalograph (EEG) demonstrated suppressed spontaneous oscillations during pain experience. Spectral power and coherence analysis of EEG also identified signatures of different types of chronic pain. Furthermore, fMRI and EEG can visualize objective brain activities modulated by analgesics in a mechanism-based way, thus bridge the gaps between animal studies and clinical trials. Using fMRI and EEG, researchers are able to predict therapeutic efficacy and identify personalized optimal first-line regimens. In the future, the emergence of magnetic resonance spectroscopy and cell labelling in MRI would encourage the investigation on metabolic and cellular pain biomarkers. The incorporation of machine learning algorithms with neuroimaging or behavior analysis could further enhance the specificity and accuracy of objective pain assessments.
A replicable and generalizable neuroimaging-based indicator of pain sensitivity across individuals

Li-Bo Zhang,Xuejing Lu,Huijuan Zhang,Zhaoxing Wei,Yazhuo Kong,Yiheng Tu,Giandomenico Iannetti,Li Hu

DOI: https://doi.org/10.1101/2024.06.08.597884

2024-07-27

Abstract:Developing neural indicators of pain sensitivity is crucial for revealing the neural basis of individual differences in pain and advancing individualized pain treatment. To identify reliable neural indicators of pain sensitivity, we leveraged five large and diverse functional magnetic resonance imaging (fMRI) datasets (total N=1010). We found replicable and generalizable correlations between pain-evoked fMRI responses and pain sensitivity for laser heat, contact heat, and mechanical pains. These fMRI responses correlated more strongly with pain sensitivity than with tactile, auditory, and visual sensitivity. Moreover, we developed a machine learning model that accurately predicted not only pain sensitivity but also pain relief from different analgesic treatments. Notably, these findings were influenced considerably by sample sizes, requiring >200 for univariate correlation analysis and >150 for multivariate machine learning modelling. Altogether, we demonstrate the validity of decoding pain sensitivity and predict analgesic effects using fMRI responses, offering clinical promise in tailoring individualized pain treatments.

Neuroscience
Automatic pain quantification using autonomic parameters

P. Werner,A. Al-Hamadi,Gustavo Moreira da Silva,Sascha Gruss,Steffen Walter,A. Andrade,Nicolai Diniz,K. Limbrecht-Ecklundt,H. Traue

DOI: https://doi.org/10.3922/J.PSNS.2014.041

2014-12-01

Abstract:objective measurement of subjective, multi-dimensionally experienced pain is a problem for which there has not been an adequate solution. Although verbal methods (e.g., pain scales and questionnaires) are commonly used to measure clinical pain, they tend to lack objectivity, reliability, or validity when applied to mentally impaired individuals. Biopotential and behavioral parameters may represent a solution. Such coding systems already exist, but they are either very costly or time-consuming or have not been sufficiently evaluated. In this context, we collected a database of biopotentials to advance an automated pain recognition system, determine its theoretical testing quality, and optimize its performance. For this purpose, participants were subjected to painful heat stimuli under controlled conditions. One hundred thirty-five features were extracted from the mathematical groupings of amplitude, frequency, stationarity, entropy, linearity, and variability. The following features were chosen as the most selective: (1) electromyography corrugator peak to peak, (2) corrugator shannon entropy, and (3) heart rate variability slope RR. Individual-specific calibration allows the adjustment of feature patterns, resulting in significantly more accurate pain detection rates. The objective measurement of pain in patients will provide valuable information for the clinical team, which may aid the objective assessment of treatment (e.g., effectiveness of drugs for pain reduction, information on surgical indication, and quality of care provided to patients).

Medicine,Psychology

Brian's breakthrough in cancer diagnosis.

Using sensor-fusion and machine-learning algorithms to assess acute pain in non-verbal infants: a study protocol

Multimodal physiological sensing for the assessment of acute pain

Brain-Computer Interface to Deliver Individualized Multisensory Intervention for Neuropathic Pain

Advancing the integration of biosignal-based automated pain assessment methods into a comprehensive model for addressing cancer pain

Pain chronification risk assessment: advanced phenotyping and scoring for prediction and treatments tailored to individualized patient profile

Emotion Processing in Peripheral Neuropathic Pain: An Observational Study

Disease Phenotypes in Refractory Musculoskeletal Pain Syndromes Identified by Unsupervised Machine Learning

Naturalistic acute pain states decoded from neural and facial dynamics

Targeted neural stimulation congruent with immersive reality decreases neuropathic pain

Two new cyclophilins from Fusarium sambucinum and Aspergillus niger: resistance of cyclophilin/cyclosporin A complexes against proteolysis.

Predicting pain genes: multi-modal data integration using probabilistic classifiers and interaction networks

BLOOD PROTEOMICS AND PAIN - A TRANSLATIONAL STUDY TO PROGNOSTICATE PAIN PHENOTYPES AND ASSESS NEW BIOMARKERS FOR PREVENTING PAIN IN HUMANS

Physiological and behavioral profiling for nociceptive pain estimation using personalized multitask learning

Experimental Exploration of Objective Human Pain Assessment Using Multimodal Sensing Signals

PainMeter: Automatic Assessment of Pain Intensity Levels From Multiple Physiological Signals Using Machine Learning

Feasibility interventional study investigating PAIN in neurorehabilitation through wearabLE SensorS (PAINLESS): a study protocol

PainPoints: A Framework for Language-based Detection of Chronic Pain and Expert-Collaborative Text-Summarization

Objective Pain Assessment: a Key for the Management of Chronic Pain

A replicable and generalizable neuroimaging-based indicator of pain sensitivity across individuals

Automatic pain quantification using autonomic parameters